SciClone acquiring NovaMed Pharmaceuticals in a cash and stock deal valued at $104.8M

NovaMed Pharmaceuticals Inc.

China / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

SciClone Pharmaceuticals Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed